baber/WOPTO huggingface dataset:
Patent AU-724115-B2 (AU)
Title: A method for treating allergic and inflammatory diseases and for inhibiting the production of tumor necrosis factor
Inventor: IV SIEGFRIED BENJAMIN CHRISTEN
IPC: C07C319/12
Filed: 1999-06-24
Granted: 2000-09-14
Abstract: Novel compounds of Formula (I) <CHEM> are described herein. These compounds inhibit the production of Tumor Necrosis Factor and are useful in the treatment of disease states mediated or exacerbated by TNF production. The compounds of the present invention are also useful in the mediation or inhibition of enzymatic or catalytic activity of phosphodiesterase IV and are therefore useful in the treatment of disease states in need of mediation or inhibition thereof.
Patent AU-704784-B2 (AU)
Title: Method for the detection of ras oncogenes, in particular the K-ras oncogene
Inventor: BREIVIK JARLE
IPC: C12Q1/6886
Filed: 1995-11-10
Granted: 1999-05-06
Abstract: PCT No. PCT/GB95/02644 Sec. 371 Date Aug. 22, 1997 Sec. 102(e) Date Aug. 22, 1997 PCT Filed Nov. 10, 1995 PCT Pub. No. WO96/15262 PCT Pub. Date May 23, 1996The invention relates to an oligonucleotide primer sequence for use in in vitro amplification, characterised in that said primer sequence is capable of creating a BstX I restriction site overlapping codon (12) and/or an Xcm I restriction site overlapping codon (13) or a Bce 83I restriction site overlapping codon (61) of the wild-type K-ras oncogene, methods of using said primer sequences for detecting activating mutations in codons (12 and/or 13 and/or 61) of the K-ras oncogene and kits for performing the methods.
Patent AU-668725-B2 (AU)
Title: Process for the production of purified terephthalic acid
Inventor: TURNER JOHN ARTHUR
IPC: F28C3/06
Filed: 1993-05-20
Granted: 1996-05-16
Abstract: A process for the production of purified terephthalic acid (PTA) from crude terephthalic acid (CTA) comprising mixing the CTA with an aqueous medium to form an aqueous CTA mixture, heating the mixture to dissolve substantially all of the CTA in the aqueous medium by introducing into the aqueous mixture vapour having a temperature greater than that of said mixture and then chemically reducing impurities in the aqueous solution of CTA followed by recovery of PTA by a crystallisation process. The vapour is typically steam derived from the crystallisation process and may be introduced into the aqueous CTA mixture by means of an injection device (30) (Figures 2 and 3).
Patent AU-760724-B2 (AU)
Title: Dispensing liquids
Inventor: LEONARD STEPHEN BOWNE
IPC: E03D9/03
Filed: 1999-06-15
Granted: 2003-05-22
Abstract: A liquid dispenser 1 comprises a housing 2 and a hook 3 for suspending the housing 2 from the rim of a lavatory bowl. A user inserts a sealed inverted reservoir bottle 6 into the housing 2, which breaks the seal. A porous pad 7 located in the housing 2 conveys liquid from the bottle 6 to a position within the stream of flushing water. <??>The pad 7 can be adjusted to accommodate different lavatories and has two guide slots which are engaged by two fingers in the housing which define two extreme positions of the pad 7. <??>To allow venting of the bottle 6, small vent holes 14 are formed in the pad 7. <??>The pad may alternatively be a solid plate of the same shape but having a number of raised holes or elongate slots. The plate may be have a venting post which mates with the mouth of the bottle 6. <??>Venting may be achieved by providing an aperture in the bottle. The top of the bottle may be provided with: a one-way valve; with a plug which seals the aperture, the housing having a pin which bears on the plug and releases it into the bottle; a breakable seal which covers the aperture, the housing being provided with a tube member which seals the aperture; or a removable tab which covers the aperture and which is broken away from the bottle prior to insertion, either by the user or, automatically, by a projection within the housing. <IMAGE>
Patent AU-718575-B2 (AU)
Title: Process for producing diothiobis-alkanesulfonates and phosphonates
Inventor: HARIDAS KOCHAT
IPC: C07C323/66
Filed: 1997-09-23
Granted: 2000-04-13
Abstract: A process for synthesizing disulfides and sulfhydryl compounds which are useful pharmaceuticals. The process includes a two step, single pot process for preparing disulfides from an alkenyl sulfonate salt. The disulfides are useful as toxicity mitigating agents of chemotherapeutic drugs, such as certain platinum complexes, and as use therapeutic drugs for a variety of conditions in mammals. The two step process involves first the conversion of the starting reagent to a mercaptane sulfonate, then an oxidation to the desired disulfide.
Patent AU-704540-B2 (AU)
Title: An acoustical echo canceller with sub-band filtering
Inventor: BOUDY JEROME
IPC: H04M9/08
Filed: 1995-12-27
Granted: 1999-04-29
Abstract: PCT No. PCT/FR95/01743 Sec. 371 Date Aug. 28, 1996 Sec. 102(e) Date Aug. 28, 1996 PCT Filed Dec. 27, 1995 PCT Pub. No. WO96/21313 PCT Pub. Date Jul. 11, 1996The echo canceller is designed to be placed between a hands-free acoustical interface and a communications network. It comprises a plurality of processing paths connected in parallel and each allocated to one of a plurality of adjacent sub-bands taken from the spectrum band of the output signal. Each path comprises an analysis filter receiving the echo-containing signal for transmission after correction, a second analysis filter receiving the incoming signal coming from the network, and feeding an adaptive filter that supplies an estimated echo in the respective sub-band to the subtractive input of the subtracter and a synthesis filter. The adaptive filters in at least some of the sub-bands implement a QR decomposition RLS algorithm on the incoming signal, using the fast version thereof, with or without recursive order.
Patent AU-667739-B2 (AU)
Title: Condensed heterocyclic compounds, their production and use
Inventor: NATSUGARI HIDEAKI
IPC: C07D217/26
Filed: 1993-09-03
Granted: 1996-04-04
Abstract: Novel compound represented by the formula: <CHEM>  wherein ring A may be substituted;  ring B represents an optionally substituted benzene ring; either X or Y represents -NR<1>- (R<1> represents a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted hydroxyl group or an optionally substituted amino group), -O- or -S-, the other representing -CO-, -CS- or -C(R<2>)R<2a>- (R<2> and R<2a> independently represent a hydrogen atom or an optionally substituted hydrocarbon group), or either X or Y represents -N=, the other representing =CR<3>- (R<3> represents a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group , an optionally substituted amino group, a substituted hydroxyl group or a mercapto group substituted by an optionally substituted hydrocarbon group);  <........> represents a single or double bond; when <........> is a single bond, Z represents -CR<4>- (R<4> represents a hydrogen atom, hydroxyl group or an optionally substituted hydrocarbon group) or a nitrogen atom, or (ii) when <........> is a double bond, Z represents a carbon atom; D represents a C1-3 alkylene group which may be substituted by an oxo group or a thioxo group, or D and Y, taken together, may form a 5- to 7-membered ring which may be substituted by an oxo group or a thioxo group; E represents -NR<5>- (R<5> represents a hydrogen atom or an optionally substituted hydrocarbon group), -O- or -S(O)n- (n is 0,1 or 2), or R<5> and Y, taken together, may form a 5- to 7- membered ring which may be substituted by an oxo group or a thioxo group;  G represents a bond or a C1-3 alkylene group; Ar represents an optionally substituted aryl group or an optionally substituted heterocyclic group, provided that (1) when (i) -X-Y- represents - O-CO- or -CO-O-, (ii) D represents -CO- and (iii) E represents -NR<5>-, either (a) G represents a C1-3 alkylene group and Ar represents a substituted aryl group or a substituted heterocyclic group, or (b) G represents a bond and R<5> represents an optionally substituted hydrocarbon group, and (2) when -X-Y- represents -NH-CO-, D represents -CO-, or a salt thereof having an excellent activity of inhibiting ACAT, lowering chlesterol in blood and inhibiting tachykinin recepter, or a salt thereof, their production and use.
Patent AU-576615-B2 (AU)
Title: Microbial-resistant non-woven material
Inventor: FAWKES DAVID MELVILLE
IPC: D21H21/36
Filed: 1985-08-13
Granted: 1988-09-01
Abstract: @ There is disclosed a non-woven material having a superficial coating of a linear polymeric biguanide in which the recurring unit is of the formulawherein X and Y, which may be the same or different, represent bridging groups in which the total number of carbon atoms in X and Y taken together, directly interposed between the pairs of nitrogen atoms linked thereby is from 10 to 16, or the salt thereof with an acid. Preferably the polymeric biguanide is polyhexamethylene biguanide dihydrochloride. The material is useful in the form of an article designed for the collection of human body emissions, more particularly disposable nappies, to avoid bacterial activity.
Patent AU-692062-B2 (AU)
Title: Method of preparing retroviral protease inhibitor intermediates
Inventor: NG JOHN S
IPC: C07C213/10
Filed: 1996-01-18
Granted: 1998-05-28
Abstract: The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
Patent AU-622295-B2 (AU)
Title: Manufacture of 1,1,1,2-tetrafluoroethane
Inventor: MANZER LEO ERNEST
IPC: C07C17/20
Filed: 1990-01-03
Granted: 1992-04-02
Abstract: This invention provides an improved process for the manufacture of 1,1,1,2-tetrafluoroethane by the reaction of HF and trichloroethylene in the presence of a catalyst to form a mixture comprising 2-chloro-1,1,1-trifluoroethane and 1,1,1,2-tetrafluoroethane and, optionally, other organic by-products. The improvement resides in conducting the reaction in a single reaction zone while recovering the 1,1,1,2-tetrafluoroethane from the mixture and recycling the 2-chloro-1,1,1-trifluoroethane and, optionally, other organic by-products from the mixture to the reaction along with trichloroethylene and HF.
Patent AU-574559-B2 (AU)
Title: Universal connector
Inventor: STOEWE ANNELIESE
IPC: H01R13/506
Filed: 1986-01-24
Granted: 1988-07-07
Abstract: In a universal connector (1) for a solderless, screwless and stripless system in which the opposing leaf spring arms of a contact element are oppositely torqued upon insertion of the conductor between them at a 45 DEG  angle. The connector is intended for testing, connecting and isolating conductor tracks. It is possible with this invention to obtain a twofold utilizability and thus an inexpensive manufacture of the shell halves (2, 2a) of the universal connector (1) by the fact that in two identical shell halves (2, 2a) of the universal connector (1) there are provided with either two contact blades (3, 3a) or a printed board (4).
Patent AU-621476-B2 (AU)
Title: Improved formulations having enhanced water dissolution
Inventor: KAJIKAWA AKIRA
IPC: A01N25/14
Filed: 1990-04-12
Granted: 1992-03-12
Abstract: This invention relates to dry, water soluble, pesticidally acceptable particulate compositions, to a method of use thereof for killing or controlling pests including weeds and to a process for preparing such compositions. This invention also relates to dry, water soluble and/or water dispersible, pesticidally acceptable particulate herbicidal compositions ccntaining one or more herbicides, a herbicidal method of use thereof and to a process for preparing such compositions. The dissolution or dispersible rates of particulate pesticidal compositions in water are enhanced by the presence of a small but effective amount of an organosilicone block copolymer wetting agent or a fluorocarbon wetting agent.
Patent AU-682332-B2 (AU)
Title: Novel selective aromatase inhibiting compounds
Inventor: KARJALAINEN ARTO JOHANNES
IPC: C12N9/99
Filed: 1993-12-14
Granted: 1997-10-02
Abstract: PCT No. PCT/FI93/00539 Sec. 371 Date May 19, 1995 Sec. 102(e) Date May 19, 1995 PCT Filed Dec. 14, 1993 PCT Pub. No. WO94/13645 PCT Pub. Date Jun. 23, 1994New compounds of formula (I) wherein R1 is H, CH3, OCH3, NO2, NH2, CN, CF3, CHF2, CH2F or halogen, R2 is a heterocyclyl radical selected from 1-imidazolyl, triazolyl, tetrazolyl, pyrazolyl, pyrimidinyl, oxazolyl, thiazolyl, isoxazolyl and isothiazolyl, R3 is H or OH, R4 is H, R5 is H or OH; or R4 is H and R3 and R5 combined form a bond; or R3 is H and R4 and R5 combined form -(O); R6 is methylene, ethylene, -CHOH-, -CH2-CHOH-, -CHOH-CH2-, -CH-CH- or -C(-O)-; or R4 is H and R5 and R6 combined is -CH- or -CH-CH2-; stereoisomers thereof and non-toxic pharmaceutically acceptable acid addition salts thereof exhibit selective aromatase inhibiting properties, compared with their desmolase inhibiting properties. The compounds of the invention are valuable in the treatment of estrogen dependent diseases, e.g. breast cancer or benign prostatic hyperplasia (BPH).
Patent AU-708328-B2 (AU)
Title: Blood-pool imaging compositions use and method
Inventor: TOURNIER HERVE
IPC: A61K49/18
Filed: 1996-06-14
Granted: 1999-08-05
Abstract: The invention concerns NMR imaging contrast compositions comprising magnetically responsive species coupled to physiologically acceptable amphipatic organic substrate materials in the form of mixed micelles suspended or dispersed in a physiologically acceptable aqueous liquid carrier. The compositions are particularly useful for diagnostic investigations of the blood-pool. The invention also concerns the preparation of the mixed micelles, as well as of injectable compositions containing the mixed micelles as contrast agents for MRI purpose. Once injected, the mixed micelles of the compositions behave as imaging contrast enhancers, e.g. they will improve the quality and resolution of the electronically processed images obtained during MRI examinations of the circulation and/or circulation targeted organs. The compositions are formulated to protect the particles of the contrast agents from early removal by the reticulo-endothelial (RES) system of the liver and the spleen, so that they will stay in the circulation for a time sufficient to properly image the blood vessels and to be transported to selected organs. MRI imaging of the circulation and of targeted organs can strongly assist in diagnosing possible ailments in human and animal patients.
Patent AU-651317-B2 (AU)
Title: Radiation synovectomy compositions
Inventor: DEUTSCH EDWARD A
IPC: A61K51/12
Filed: 1990-06-18
Granted: 1994-07-21
Abstract: Radiation synovectomy compositions comprising a radionuclide complex selected from the group of 188-Re MAG3, 186-Re MAG3, 186-Re DADS, and 188-Re DADS bound to a substantially insoluble particle selected from the group of albumin microspheres, sulfur colloid, glass beads, albumin and latex.
Patent AU-764909-B2 (AU)
Title: Server-assisted regeneration of a strong secret from a weak secret
Inventor: FORD WARWICK S
IPC: A61K38/00
Filed: 2000-06-29
Granted: 2003-09-04
Abstract: Methods for regenerating a strong secret for a user, based on input of a weak secret, such as a password, are assisted by communications exchanges with a set of independent servers. Each server holds a distinct secret value (i.e., server secret data). The strong secret is a function of the user's weak secret and of the server secret data, and a would-be attacker cannot feasibly compute the strong secret without access to both the user's weak secret and the server secret data. Any attacker has only a limited opportunity to guess the weak secret, even if he has access to all messages transmitted in the generation and regeneration processes plus a subset (but not all) of the server secret data.
Patent AU-574592-B2 (AU)
Title: Platinum-palladium-iridium based dental alloy
Inventor: GROLL WERNER
IPC: C22C5/04
Filed: 1986-12-02
Granted: 1988-07-07
Abstract: Noble metal alloys are used to produce attachments that can be cast-on, particularly in dental technology, having a melting range above 1500 DEG  C. The alloys comprise about 40-70% platinum, about 10-40% palladium, about 5-20% iridium, about 0.5-10% gold, about 0-13 3% silver and about 0-1% each of ruthenium and rhodium.
Patent AU-682183-B2 (AU)
Title: Thick film equilibrium process and device
Inventor: SCHOFIELD RICHARD W
IPC: B01D63/08
Filed: 1994-04-18
Granted: 1997-09-25
Abstract: There is disclosed a method for removing a volatile component from a feed or process stream comprising (1) absorbing or adsorbing the volatile component into an absorbent or adsorbent material in an equilibrium process, wherein feed is pumped through a mixture chamber of a device, wherein the device comprises the mixture chamber and a vapor chamber, wherein the mixture chamber comprises a plurality of films comprising absorbent or adsorbent materials, wherein the film is configured to have a first side communicating with the mixture chamber and a second side communicating with the vapor chamber, and (2) removing the volatile component from the absorbent or adsorbent material by applying heat to the mixture chamber and simultaneously applying a gas phase within the vapor chamber such that the volatile component is collected in a gaseous state in the vapor chamber. There is further disclosed a device for removing a volatile component from a feed comprising an enclosed two-chambered device having a mixture chamber and a vapor chamber, wherein the mixture chamber comprises a plurality of absorbent or adsorbent materials configured to have a first side communicating with the mixture chamber and a second side communicating with the vapor chamber, wherein the absorbent or adsorbent materials comprise a thick film having a thickness of from about 0.1 mm to about 5 mm thick with optional protuberances.
Patent AU-581608-B2 (AU)
Title: Ether carboxylate detergent builders and process for their preparation
Inventor: BUSH RODNEY DEAN
IPC: C11D3/20
Filed: 1987-01-30
Granted: 1989-02-23
Abstract: Provided herein are ether carboxylate builder compositions comprising a combination of tartrate monosuccinic acid (or salts thereof) and tartrate disuccinic acid (or salts thereof). Such mixtures can be prepared by reacting water-soluble, mixed maleic acid salts with mixed tartaric acid salts. Both components of the resulting ether carboxylate mixture act as sequestering agents and are useful as detergency builders. Detergent and laundry additive compositions incorporating these ether carboxylates can be pre­pared without use of detergent builder components containing phosphorus or nitrogen.
Patent AU-684286-B2 (AU)
Title: Lotion
Inventor: KAGAYAMA AKIRA
IPC: A61K47/44
Filed: 1994-05-30
Granted: 1997-12-11
Abstract: A lotion comprising a tricyclic compounds represented by 17-allyl-1,14-dihydroxy-12-Ä2-(4-hydroxy-3-methoxycyclohexyl)-1-methyl vinylÜ-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-a zatricycloÄ22.3.1.0<4,9>Üoctacos-18-ene-2,3,10,16-tetrone or a pharmaceutically acceptable salt thereof, a dissolution/absorption promoter, a liquid medium, and optionally an emulsifying agent or a mixture thereof with a thickening agent. The lotion is stable and excellent in absorbability, scarcely irritates the skin, and can be sustainedly released. It is useful for treating and preventing inflammatory and proliferative dermatoses and immunologically mediated skin diseases.
Patent AU-673270-B2 (AU)
Title: Hot stamping foil
Inventor: CASPARI RUEDIGER
IPC: G09F13/16
Filed: 1994-05-13
Granted: 1996-10-31
Abstract: A hot stamping foil comprising in order a carrier, optional release control layer, color layer, and adherence layer, wherein the adherence layer comprises a mixture of ethylene copolymer dispersion and acrylic dispersion. Also a method using such foils to form graphic patterns on articles such as retroreflective license plates, stickers, or emblems and articles bearing graphic patterns formed using such foils.
Patent AU-641976-B2 (AU)
Title: Medical projector, more particularly for a surgical use
Inventor: HUBERT JEAN
IPC: F21V21/40
Filed: 1991-02-05
Granted: 1993-10-07
Abstract: The medical projector (1) consists of an illuminating dome (2)-(16) mounted so that it can swivel about various axes. It is provided on its largest periphery with a flexible protective bulb (22) of such a size as to form a system for gripping and manoeuvring the dome, and defining an inner chamber (29). This chamber, on the side facing the outer surface of the bulb (22), is bounded by a wall (31) thin enough to be deformed by manual pressure and to actuate means (32) (33-36) for controlling a device for unlocking and relocking the articulation stops of the supporting brackets. 
<IMAGE>
Patent AU-638096-B2 (AU)
Title: Novel benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation, synthesis intermediates and pharmaceutical compositions in which they are present
IPC: A61K31/415
Filed: 1991-02-07
Granted: 1993-06-17
Abstract: The present invention relates to the derivatives of the formula <IMAGE>  Formula (I)  in which: A is an aromatic ring or a nitrogen heterocycle; X1, X2, X3 and X4 are independently a hydrogen atom, a halogen atom, a lower alkyl radical, a C3-C7 cycloalkyl radical, an alkoxy radical, an alkylthio radical, a sulfone group, SO2-lower alkyl, a sulfoxide group, SO-lower alkyl, a trifluoromethyl group, a nitro group, a hydroxyl group, a methylene alcohol radical or a group COOR', in which R' is a hydrogen or a lower alkyl; X3 and X4 can also form a naphthalene with the phenyl; B is CR5R6, R5 and R6 being a hydrogen atom, a lower alkyl or a C3-C7 cycloalkyl radical, or the sulfur atom; R1, R2, R3 and R4 are independently a hydrogen atom, a lower alkyl radical or a C3-C7 cycloalkyl radical; CR1R2 or CR3R4 can form with B, when the latter is CR5R6, a cycloalkyl or a cycloalkene having 3 to 7 carbon atoms; R1R2 and R3R4 can also form a ring having 3 to 7 carbon atoms; n is an integer from 1 to 4 and can be 0 if R1 and R2 are other than hydrogen; and D is a chemical group which can be: COOR7, R7 being the hydrogen atom, a lower alky radical or a C3-C7 cycloalkyl radical, CONH-R8, R8 being the hydrogen atom, a lower alkyl radical or a C3-C7 cycloalkyl radical, or CN, and to their addition salts. The compounds are thromboxane antagonist receptors.
Patent AU-673278-B2 (AU)
Title: Cementitious compositions for layered applications
Inventor: MELBYE TOM
IPC: C04B24/26
Filed: 1994-09-06
Granted: 1996-10-31
Abstract: The interlayer adhesion and final strength of cementitious compositions which are applied in consecutive layers are improved by the incorporation in the compositions of an admixture which is a combination of a waterproofing agent and a water retention agent. The invention is particularly applicable to sprayed concrete.
Patent AU-654123-B2 (AU)
Title: Offset printing apparatus
Inventor: OOTA HIDEO
IPC: B41F7/24
Filed: 1991-03-05
Granted: 1994-10-27
Abstract: The object of the present invention is to provide an offset printing apparatus having good adhesion of ink onto the roller of the feeding route by efficiently fractionizing the dampening fluid supplied to the ink device. This invention relates to an offset printing apparatus provided with an ink device (I) and a dampening fluid device (D). Said ink device (I) has an ink feeding route including an ink metering roller (2) and an ink storage device (4) whose distance toward the revolving direction of the upstream roller (1) of said ink feeding route being gradually small. <IMAGE>
Patent AU-543587-B2 (AU)
Title: Determining liquid level
Inventor: MARTIN KEITH SIDNEY
IPC: F16N19/00
Filed: 1981-08-28
Granted: 1985-04-26
Abstract: A fluid container, e.g. in an air filter or lubricator, has a metal bowl with a sight glass comprising an elongate light-transmitting member of longitudinally tapered form. The sight glass member is slidable into a complementary tapered slot or recess defined by a flange integral with the bowl and overlying a flat wall portion provided with apertures to the main volume of the bowl and the space between said wall portion and the member adjacent top and bottom regions of the member respectively.